Literature DB >> 22520054

Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects.

Robert P Takes1, Alessandra Rinaldo, Carl E Silver, Missak Haigentz, Julia A Woolgar, Asterios Triantafyllou, Vanni Mondin, Daniela Paccagnella, Remco de Bree, Ashok R Shaha, Dana M Hartl, Alfio Ferlito.   

Abstract

The incidence of distant metastasis in head and neck squamous cell carcinoma (HNSCC) is relatively low but remains a major determinant of prognosis and therefore an important factor in clinical decision making. The most frequently involved sites for distant metastasis are the lung (approximately 70% of cases), followed by bone and liver. There are often conflicting reports on which parameters are risk factors for distant metastasis, but the most important predictive factors appear to be the site of the primary tumor (hypopharynx in particular), advanced T- and N-classification, histological grade and the ability to achieve locoregional disease control. Metastasis results from a selection of tumor cells that have acquired the properties to withstand multiple and often unfavorable circumstances and settle in distant organs. Most of these processes involve interaction between tumor cells, their microenvironment and host factors. Increasing knowledge of the biology of distant metastasis may result in the development of diagnostic and therapeutic strategies targeted to this usually terminal stage for patients with HNSCC.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22520054     DOI: 10.1016/j.oraloncology.2012.03.013

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  56 in total

1.  Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study.

Authors:  Olcay Cem Bulut; Katja Lindel; Henrik Hauswald; Regine Brandt; Frederick Klauschen; Janina Wolf; Thomas Wolf; Peter K Plinkert; Christian Simon; Wilko Weichert; Albrecht Stenzinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-29       Impact factor: 2.503

Review 2.  Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Authors:  Andrew Schrepf; Susan K Lutgendorf; Leah M Pyter
Journal:  Brain Behav Immun       Date:  2015-05-06       Impact factor: 7.217

3.  Differences between epithelial and mesenchymal human tongue cancer cell lines in experimental metastasis.

Authors:  Wei-Xin Cai; Ru Qing Yu; Li Ma; Hong Zhang Huang; Li Wu Zheng; Roger Zwahlen
Journal:  Oncol Lett       Date:  2018-04-26       Impact factor: 2.967

4.  Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.

Authors:  Mozaffarul Islam; Jharna Datta; James C Lang; Theodoros N Teknos
Journal:  Oral Oncol       Date:  2014-02-22       Impact factor: 5.337

5.  Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs.

Authors:  Jharna Datta; Mozaffarul Islam; Samidha Dutta; Sounak Roy; Quintin Pan; Theodoros N Teknos
Journal:  Oral Oncol       Date:  2016-03-19       Impact factor: 5.337

6.  CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.

Authors:  Junhee Park; Xianglan Zhang; Sun Kyoung Lee; Na-Young Song; Seung Hwa Son; Ki Rim Kim; Jae Hoon Shim; Kwang-Kyun Park; Won-Yoon Chung
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

7.  Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.

Authors:  Margret Rave-Fränk; Narges Tehrany; Julia Kitz; Martin Leu; Hanne Elisabeth Weber; Peter Burfeind; Henning Schliephake; Martin Canis; Tim Beissbarth; Holger Michael Reichardt; Hendrik Andreas Wolff
Journal:  Strahlenther Onkol       Date:  2015-09-15       Impact factor: 3.621

8.  Predictive factors for simultaneous distant metastasis in head and neck cancer patients during the diagnostic work-up.

Authors:  Carlos Miguel Chiesa-Estomba; Maria Soriano-Reixach; Ekhiñe Larruscain-Sarasola; Jon Alexander Sistiaga-Suarez; Jose Angel González-García; Amaia Sanchez-Martin; Laura Basterretxea-Badiola; Naiara Sagastibelta; Xabier Altuna-Mariezcurrena
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-07       Impact factor: 2.503

Review 9.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

Review 10.  Causes of death of patients with laryngeal cancer.

Authors:  Alfio Ferlito; Missak Haigentz; Patrick J Bradley; Carlos Suárez; Primož Strojan; Gregory T Wolf; Kerry D Olsen; William M Mendenhall; Vanni Mondin; Juan P Rodrigo; Carsten C Boedeker; Marc Hamoir; Dana M Hartl; Jennifer L Hunt; Kenneth O Devaney; Lester D R Thompson; Alessandra Rinaldo; Robert P Takes
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.